Zions Bancorporation, N.A. Alnylam Pharmaceuticals, Inc. Transaction History
Zions Bancorporation, N.A.
- $1.58 Billion
- Q4 2024
A detailed history of Zions Bancorporation, N.A. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Zions Bancorporation, N.A. holds 672 shares of ALNY stock, worth $210,423. This represents 0.01% of its overall portfolio holdings.
Number of Shares
672
Previous 592
13.51%
Holding current value
$210,423
Previous $162,000
2.47%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding ALNY
# of Institutions
720Shares Held
111MCall Options Held
978KPut Options Held
881K-
Capital World Investors Los Angeles, CA16.7MShares$5.24 Billion0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$4.09 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.99 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$2.24 Billion0.44% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.42MShares$1.38 Billion0.79% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $38.5B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...